Assembly of replication-competent hepadnavirus nucleocapsids requires interaction of core protein, polymerase and encapsidation signal (ε) with viral pregenomic RNA. The N-terminal portion (aa 1-149) of the core protein is able to self-assemble into nucleocapsids, whereas the Cterminal portion (aa 150-183) is known to interact with pregenomic RNA. In this study, two hepatitis B virus (HBV) core mutants (C144Arg and C144Lys) in which the C-terminal SPRRR (SerPro-Arg-Arg-Arg) motif was replaced by a stretch of arginine or lysine residues were generated to test their role in pregenome encapsidation and virus maturation. Mutant or wild-type coreexpression plasmids were co-transfected with a core-negative plasmid into human hepatoma HuH-7 cells to compare trans-complementation efficiency for virus replication. Both low-and highdensity capsids were present in the cytoplasm and culture medium of HuH-7 cells in all transfections. Nucleocapsids formed by C144Arg and C144Lys, however, lost the endogenous polymerase activity to repair HBV DNA. Furthermore, in co-transfection of pHBVC144Arg or pHBVC144Lys with a plasmid which produces replication-competent nucleocapsids, the HBV DNA repairing signal was reduced 40-to 80-fold. This is probably due to formation of mosaic particles of wild-type and mutant cores. Results indicated that the SPRRR motif at the core protein C terminus is important for HBV DNA replication and maturation. Additionally, triple-plasmid transfection experiments showed that nucleocapsids containing various amounts of C144Arg and wild-type core proteins exhibited a bias in selecting a shorter pregenome for encapsidation and DNA replication. It is therefore suggested that unknown factors are also involved in HBV pregenome packaging.
Introduction
Human hepatitis B virus (HBV), woodchuck hepatitis virus, ground squirrel hepatitis virus and duck hepatitis B virus (DHBV) are members of the family Hepadnaviridae (Gust et al., 1986) . Hepadnaviruses are partially double-stranded DNA viruses which have a typical icosahedral nucleocapsid and are enveloped by a lipid bilayer with surface antigens (Tiollais et al., 1981 ; Ganem & Varmus, 1987) . HBV DNA is 3n2 kb long and encodes core (C), polymerase (P), surface (S) and X genes. The virus replicates its DNA genome through reverse transcription of its pregenomic RNA intermediate (Summers & Mason, 1982 ; Ganem & Varmus, 1987 ; Nassal & Schaller, 1993) . This reaction takes place inside the nucleocapsid which into nucleocapsid-like particles (Cohen & Richmond, 1982 ; Nassal, 1988 ; Gallina et al., 1989 ; Birnbaum & Nassal, 1990 ; Kann & Gerlich, 1994) and can encapsidate RNA nonspecifically (Pasek et al., 1979) . Studies using truncated HBV core protein have also shown that aa 10-144 are responsible for self-assembly into nucleocapsids (Gallina et al., 1989 ; Birnbaum & Nassal, 1990 ; Zheng et al., 1992) . In addition, the C terminus of the core protein is required for pregenome encapsidation and modulates the activity of polymerase for reverse transcription of the RNA pregenome and binding to the elongating DNA (Hatton et al., 1992 ; Nassal, 1992) .
The C-terminal 33 aa of HBV core proteins contain 16 (adr and ayw) or 17 (adw) arginine (R) residues ; 14 of them are clustered into four arginine repeats (I-IV) (Tiollais et al., 1981) . Previous studies have indicated that this arginine-rich domain is important for pregenome encapsidation and genomic DNA binding (Birnbaum & Nassal, 1990 ; Hatton et al., 1992 ; Nassal, 1992) . In the HBV core protein, the arginine-rich domain appears in three SPRRR (Ser-Pro-Arg-Arg-Arg) motifs. In the DHBV core protein, the nucleic acid-binding domain is located at aa 181-228, which has ten arginine and five lysine residues but no SPRRR motif (Sprengel et al., 1985) . It is therefore of interest to know whether an HBV core protein in which the Cterminal SPRRR motif is replaced by a stretch of arginine or lysine residues, similar to that of DHBV, still retains its function for pregenome encapsidation and viral DNA maturation.
Methods
Plasmid constructions. Cloning of various plasmids was performed by standard techniques (Sambrook et al., 1989) . HBV plasmid pMH 3\3097 (Fig. 1 a, line 1) of subtype ayw (Junker et al., 1987) was obtained from Heinz Schaller (University of Heidelberg, Germany). pHBVC144j6 ( Fig. 1 a, line 2) is an expression construct for C-terminal truncated core protein (C144j6) harbouring 144 aa of core protein and 6 aa ( Fig. 1 b) encoded by a synthetic linker. This construct was generated from pMH 3\3097 by cleavage at the unique BspE1 and NcoI site followed by adding a synthetic linker containing EcoRI and XhoI cutting site and stop codons : 5h CCGGGAATTCCTCGAGTAGTCTAG-ACTAG 3h and 3h CTTAAGGAGCTCATCAGATCTGATCGTAG 5h. pHBVC144Arg ( Fig. 1 a, line 3) is an expression construct for truncated and mutated core protein (C144Arg) which is composed of 144 aa from HBV core protein plus seven arginine residues and seven amino acids ( Fig. 1 b) encoded by a synthetic linker. For construction, pHBVC144j6 was cut by EcoRI and XhoI. A specific in-frame polyarginine linker (5h AATTCGCCGCCGCCGCCGCCGCCGC 3h and 3h GCGGCGGCGG-CGGCGGCGGCGAGCT 5h) was ligated to the EcoRI-and XhoIdigested pHBVC144j6. pHBVC144Lys ( Fig. 1 a, line 4) is an expression construct for truncated and mutated core protein (C144Lys ; Fig. 1 b) which is composed of 144 aa from HBV core protein plus seven lysine residues and seven amino acids encoded by a synthetic linker. The specific in-frame duplex of polylysine linker (5h AATTAAGAAGAAGAAG-AAGAAGAAG 3h and 3h TTCTTCTTCTTCTTCTTCTTCAGCT 5h) was inserted into the EcoRI and XhoI site of plasmid pHBVC144j6. pHBV∆PSX ( Fig. 1 a, line 5 ) was constructed by deleting the 1n3 kb XhoI\AatII HBV fragment encompassing P, S and X genes from pMH 3\3097. pHBV∆C ( Fig. 1 a, line 6 ) was constructed by replacing the 2n4 kb XbaI (filled-in)\SphI fragment from the pMH 3\3097 with the 2n2 kb HindIII (filled-in)\SphI fragment from the pHBVP (Lin & Lo, 1992 ; Lin et al., 1995) . For construction of control plasmid pUC-MT (without HBV sequence ; Fig. 1 a, line 9) , the HindIII\SmaI HBV fragment was excised from pMH 3\3097. All junctions of new clones were verified by DNA sequencing (Sanger et al., 1977) using a commercial kit (Amersham Pharmacia Biotech).
Cell culture and transfection. The human hepatoma cells HuH-7 were grown in Dulbecco's modified Eagle's medium supplemented with 10 % foetal bovine serum, 1 mM glutamine, 10 U\ml penicillin and 100 µg\ml streptomycin. For transfection, HuH-7 cells were transfected with the appropriate plasmids alone or in combination, using the calcium phosphate co-precipitation procedure (Graham & van der Eb, 1973 ; Sambrook et al., 1989) . At 3, 6 and 9 days post-transfection, medium was harvested for virus isolation. At 9 days post-transfection, cells were harvested for analysis of cellular nucleocapsid and viral DNA.
Immunoprecipitation and Western blotting analysis. Transfected HuH-7 cells were lysed in NET buffer (50 mM Tris, pH 7n5, 150 mM NaCl, 0n5 mM EDTA and 0n5 % NP-40). Lysates were centrifuged to remove insoluble cell debris and were cleared by protein A-Sepharose (Amersham Pharmacia Biotech). The supernatant was then incubated with rabbit anti-core (Dako) or mouse anti-Flag (M2 ; Eastman Kodak) antiserum with protein A-Sepharose complexes. The beads were subsequently washed four times with NET buffer and the complexes were boiled in reducing sample buffer and resolved by 15 % SDS-PAGE (Laemmli, 1970) . Western blotting was then performed as described by Towbin et al. (1979) and a protein-antibody complex was detected by rabbit anti-core antibody and subsequently developed by enhanced chemiluminescence.
Viral nucleocapsid isolation.
To collect nucleocapsids from intracellular extract, transfected cells were collected and incubated in PBS with 1 % NP-40 at 4 mC overnight (Beames & Lanford, 1995) . After a lowspeed centrifugation to remove nuclei and NP-40-insoluble cell debris, the cellular lysate was collected. To collect nucleocapsids from culture fluids, the media were incubated with NP-40 to a final concentration of 1 % at room temperature for 2 h and then clarified by centrifugation at 13 000 r.p.m. in a JA-20 rotor for 30 min. The viral nucleocapsids from cellular lysate and medium were then concentrated by centrifugation at 45 000 r.p.m. in a Ti55.2 rotor for 2n5 h. The isolated viral nucleocapsids were resuspended in low-salt TNE buffer (10 mM Tris-HCl, pH 7n5, 100 mM NaCl and 1 mM EDTA).
CsCl gradient centrifugation. The isolated nucleocapsids were resuspended in high-salt TNE buffer (10 mM Tris-HCl, pH 7n4, 150 mM NaCl, 1 mM EDTA and 0n1 % sodium azide) and subjected to CsCl centrifugation (average density 1n24 g\ml, final density 1n1-1n5 g\ml) at 35 000 r.p.m. in an SW41 rotor for 44 h. The gradients were fractionated into 0n5 ml samples from the top and each fraction was subjected to ELISA for detection of core antigen (General Biologicals). The density of individual fractions was determined by the refractive index using a refractometer.
Endogenous DNA polymerase assay. Endogenous DNA polymerase activity assay was performed as described previously (Junker et al., 1987) with modification (Chiang et al., 1990 ; Lin & Lo, 1992) . Briefly, one-fifth of the partially purified virus particle samples was incubated with pol-mix buffer (50 mM Tris-HCl, pH 7n4, 40 mM NH % Cl, 5 mM MgCl # , 0n5 % NP-40, 0n2 % 2-mercaptoethanol, and 25 µM each of dATP, dGTP and dTTP) at 37 mC for 2 h in the presence of [α-$#P]dCTP (5000 mCi\mmol ; Amersham). Subsequently, a chase was performed for 2 h by adding unlabelled dCTP (25 µM final concentration) at 37 mC. Contaminated nucleic acids were digested by micrococcal nuclease (5 U) for 1 h at 37 mC. Proteins were digested by 50 µg\ml proteinase K treatment in the presence of 1 % SDS for 1 h at 37 mC. If necessary, $#P-labelled 3\3097 HindIII-digested plasmid (6n4 kb) was added as a control for technical error. Glycogen was added (0n8 mg\ml final concentration) and samples were then extracted with an equal volume of phenol\ chloroform. An aqueous portion was then collected and desalted, and unincorporated dNTPs were removed by a 1 ml Sephadex G-50 gel filtration column in TE buffer (10 mM Tris-HCl, pH 7n5 and 0n1 mM EDTA). The labelled DNA species were adjusted to 0n3 M sodium acetate (pH 4n8) and then precipitated with 2n5 vol. ethanol ; DNAs were then separated on 1 % agarose gels by electrophoresis and autoradiographed.
In vitro kinase assay. The immunoprecipitated nucleocapsids were washed three times and then incubated in kinase reaction buffer (50 mM Tris-HCl, pH 7n4, 10 mM MgCl # and 0n4 % NP-40) and 10 pmol [γ-$#P]ATP (7000 Ci\mmol ; Amersham) as described previously (Jeng et al., 1991 ; Lin & Lo, 1992) . After incubation at 37 mC for 1 h, the complex was washed five times with NET buffer and then subjected to SDS-PAGE (15 %) separation and autoradiographed.
Results

Characteristics and expression of mutant core proteins
To test whether mutated HBV core proteins in which the Cterminal protamine-like domain was substituted by a stretch of arginine or lysine residues still retained the function for pregenome encapsidation and viral maturation, we constructed two plasmids, pHBVC144Arg and pHBVC144Lys ( Fig. 1 a, lines 3 and 4). They encode mutated core proteins, C144Arg and C144Lys, respectively. Fig. 1 (b) shows the features of the C terminus in wild-type C183 and core mutants C144j6, C144Arg and C144Lys. C183 has three stretches of SPRRR motifs whereas C144Arg and C144Lys have 25 aa less than C183 but contain seven extra arginine or lysine residues in a stretch to replace an SPRRR sequence of C183. The mutant C144j6 has a truncation to residue 144, followed by a nonspecific 6 aa C-terminal tail (GIPRVV).
After transfection with each plasmid expressing wild-type or mutant core proteins into HuH-7 cells, immunoprecipitation by anti-core antibodies followed by Western blot analysis showed that the migration of the mutated core proteins (C144Arg and C144Lys) was faster than that of the wild-type C183 (Fig. 2, lanes 3 and 4 vs lane 1) . This was expected because the mutated core proteins possess 25 aa residues less at the C terminus. Nevertheless, the expression efficiency of mutated core proteins was similar to that of the wild-type core in HuH-7 cells, which were transfected with an equal amount of corresponding plasmids (Fig. 2) .
Formation of heavy particles from the mutant core proteins
Mutations introduced into the C terminus of the core protein cause mutations in the polymerase coding region which interferes with virus replication. In order to complement this function, pHBV∆C (Fig. 1 a, line 6 ) was used in cotransfections to supply polymerase and pregenomic RNA. For comparison with normal core protein, another plasmid, pHBV∆PSX, which has a deletion of large portions of the P, S and X genes, was constructed ( Fig. 1 a, line 5) . To probe whether the mutant core proteins can assemble into particles from co-transfections with complement plasmids, an isopycnic CsCl density gradient centrifugation was performed (see Methods). As shown in Fig. 3 , wild-type and C-terminal arginine-or lysine-substituted core proteins from both intracellular or extracellular (media) fractions appeared in two peaks with densities of 1n18-1n20 g\ml and 1n26-1n31 g\ml, respectively, corresponding to the density of light (empty) and heavy core particles (Fig. 3 a, b and c) . Results also indicated that both C144Arg and C144Lys assembled into light nucleocapsids to a lesser degree than heavy nucleocapsids. In contrast, few heavy core particles were formed by the Cterminal truncation core protein (C144j6) (Fig. 3 d) , implying that the positively charged amino acid residues present at the C terminus of C183, C144Arg and C144Lys might recruit nucleic acids into the heavy particles. In addition, an increased secretion of heavy core particles was observed in C144Arg-and C144Lys-expressing cells.
Nucleocapsids formed by mutant core proteins lose the endogenous polymerase activity
To further elucidate whether the nucleocapsids formed by mutant core proteins could specifically encapsidate HBV nucleic acids and retain a functional viral polymerase, an endogenous polymerase activity assay (so-called DNA repairing assay) was performed on nucleocapsids obtained from intracellular extracts and media of the complementation experiments. As shown in Fig. 4 , nucleocapsids encoded by the wild-type HBV-containing plasmid (pMH 3\3097 ; Fig. 1 a, line 1) produced a single band of 3n2 kb from the intracellular extract and medium (Fig. 4, lanes 2 and 6, respectively) . Nucleocapsids from co-transfection of pHBV∆C and pHBV∆PSX also produced two distinct bands of 3n0 kb (expected from pHBV∆C) and 1n9 kb (expected from pHBV∆PSX) from the intracellular extract and medium (Fig. 4,  lanes 1 and 5, respectively) . The intensity of two bands of 3n0 kb and 1n9 kb was in a ratio of about 2 : 1, as quantified by densitometry. However, both nucleocapsids from co-transfection of pHBVC144Arg or pHBVC144Lys with pHBV∆C in the intracellular extract or medium produced neither a 3n0 kb band (expected from pHBV∆C) nor a 1n0 kb band (expected from pHBVC144Arg or pHBVC144Lys) after endogenous polymerase reaction (Fig. 4, lanes 3, 4 and 7, 8, respectively) . Taking all results together, we suggest that C144Arg and C144Lys do not have fully functional endogenous polymerase activity as in the wild-type C183 (Fig. 4, lanes 3, 4 and 7, 8 vs. lane 1 and 5), although they could form heavy nucleocapsids.
Co-expression of mutant and wild-type core proteins reduced the level of virus maturation
Since the core mutants C144Arg or C144Lys failed to show replication competence by the endogenous polymerase assay, it was interesting to know whether these mutants could influence the function of wild-type core proteins in viral pregenome encapsidation and genome maturation. HuH-7 cells were co-transfected with wild-type plasmids (pMH 3\3097) and mutant plasmids (pHBVC144Arg or pHBVC144Lys) in a ratio of 1 : 9 and the intracellular nucleocapsids were analysed by endogenous polymerase activity. Two notable features were observed. (1) The intensity of the repaired 3n2 kb DNA band expected from the pregenome transcribed by pMH 3\3097 was reduced about 40-to 80-fold in the presence of C144Arg or C144Lys (Fig. 5,  lanes 3 and 4) . (2) Trans-complementation occurred between the wild-type and mutant core pregenome and resulted in the appearance of 1n0 kb HBV DNA (expected from pHBVC144Arg or pHBVC144Lys ; see Fig. 5, lanes 3 and 4) . Consistently, an 8-to 40-fold reduction in repaired full-length HBV DNA was observed in co-transfection with two other core mutants, pFlagC151 and pHBVC144j6 (Fig. 1 a, lines 7 and 2, respectively), with pMH 3\3097, but no transcomplementation was detected by the appearance of a second band of repaired HBV DNA (Fig. 5, lanes 5 and 6) . To rule out the possibility that the reduction of 3n2 kb DNA in the cotransfection experiments was due to a technical error, the 6n4 kb $#P-labelled plasmid was added in the samples during viral DNA preparation. The 6n4 kb band of similar intensity shown in all conditions supported the notion that C144Arg and C144Lys exerted a dominant, negative effect on HBV replication.
Mosaic particles formed by the full-length and Cterminal truncated core proteins retained the kinase activity
To confirm that the dominant negative effect exerted by C144Arg and C144Lys was indeed through the formation of mosaic nucleocapsids with wild-type C183, we used two core proteins, HisC183 with a His-tag fused with full-length core protein (Fig. 1 a, line 8 ) and FlagC151 with a Flag-tag fused with core protein truncated to residue 151 (Fig. 1 a, line 7) , to examine the possibility of forming mosaic particles. After a 3 day transfection with various combinations of plasmids, nucleocapsids were harvested with anti-core or anti-Flag antibodies from cell extracts and assayed for kinase activity in vitro. As shown in Fig. 6 (a) , HisC183 showed a phosphorylation signal in anti-core precipitated nucleocapsids, which were harvested either from two-plasmid transfection (pHBV∆C and pHisC183) or from triple-plasmid transfection (pHBV∆C, pHisC183 and pFlagC151) (Fig. 6, lanes 2 and 4) . If no mosaic particles formed by FlagC151 and HisC183 in the triple-plasmid transfection, negative phosphorylation of HisC183 would be obtained in the anti-Flag antibody precipitated nucleocapsids. Positive results for phosphorylation of HisC183 (Fig. 6 b, lane 4) clearly demonstrated that FlagC151, although it has a C-terminal truncation, can form mosaic particles with a full-length core of HisC183 and retain kinase activity. Western blot results showed that FlagC151 was properly expressed (Fig. 6 c, lanes 3 and 4) but was not phosphorylated in the mosaic particles (Fig. 6 b, lane 4) . This result confirmed previous observations that the phosphorylation site of the core protein is indeed located at aa 152-183 (Liao & Ou, 1995) .
Mosaic particles containing various amounts of mutant cores could result in different pregenome packaging
To extend the above observation, experiments of tripleplasmid transfection were performed to see whether C144Arg and C144Lys mutant cores also exert a dominant negative effect on trans-complementation between pHBV∆C and pHBV∆PSX for HBV DNA maturation. An equal amount (13 µg) of pHBV∆C and pHBV∆PSX was co-transfected with various amounts (0, 4, 7 or 13 µg) of pHBVC144Arg into HuH-7 cells ; nucleocapsids collected from media of all transfections were analysed by endogenous polymerase activity as described above. As shown in Fig. 7 , two distinct bands of 3n0 kb and 1n9 kb in a ratio of about 2 : 1 were produced from pHBV∆C, pHBV∆PSX and pUC-MT cotransfected cells (Fig. 7, lane 1) , which is consistent with the results shown in Fig. 4 . These two bands were barely detectable in the samples of co-transfection with 13 µg pHBVC144Arg (Fig. 7, lane 2) . When the amount of pHBVC144Arg was reduced to 7 or 4 µg in the triple-plasmid transfections, the intensity of the 1n9 kb HBV DNA increased significantly and the band of 3n0 kb became visible (Fig. 7, lanes 3 and 4) . Interestingly, in the triple-plasmid transfections with various amounts of pHBVC144Arg, a 1n0 kb species was present with constant intensity (Fig. 7, lanes 2-4) . This is presumably derived from the pregenomic RNA transcribed from the pHBVC144Arg plasmid. It might be the first demonstration that three different sizes of pregenomic RNA could be encapsidated in one transfection experiment. Moreover, the intensity of the 3n0\1n9 kb bands was reversed to a 1 : 7 ratio in Fig. 3 . Density gradient analysis of medium-(right-hand column) and cytoplasm-derived (left-hand column) HBV particles. HuH-7 cells were transfected with plasmids as indicated in Fig. 2 and samples were subjected to CsCl gradient density the presence of 4 µg pHBVC144Arg (Fig. 7, lane 4) . Although the underlying mechanism is unknown, it clearly demonstrated that C144Arg can influence the wild-type core proteins either to package different sizes of pregenomic RNA or to prevent longer pregenomes from reaching DNA maturation.
Discussion
The protamine-like domain located at the C terminus of HBV core protein is known to be important for binding to nucleic acids (Gallina et al., 1989) . To further characterize the arrangement of SPRRR in the protamine domain of the core protein that is essential for pregenome encapsidation and DNA maturation, we replaced the highly charged C-terminal 33 aa of core protein with shorter 7 aa positively charged motifs to generate C144Arg and C144Lys. Consistent with previous studies showing that the core protein truncated to residue 144 still retains the capability to assemble into capsids (Birnbaum & Nassal, 1990 ; Crowther et al., 1994 ; Zlotnick et al., 1996) , in this study, we have demonstrated that C144Arg and C144Lys could form nucleocapsids (Fig. 3) . However, sedimentation as described in the Methods. Twenty fractions (500 µl each) were collected and analysed for the presence of core protein by ELISA. The density (g/ml) of individual fractions is shown (dotted line) in each panel. The closed circles show the ELISA OD 490 readings in each fraction. trans-complementation studies combined with an endogenous polymerase assay revealed that the capsids formed by C144Arg and C144Lys could not function in HBV DNA repairing (Fig. 4) . This result could be due to poor pregenome encapsidation or inability to bind elongating DNA as demonstrated by Hatton et al. (1992) . It may be due to the 25 aa less in C144Arg and C144Lys. Alternatively, it may result from introducing the stretch of arginine or lysine in core mutants to produce less stable capsids. The reduction in HBV DNA maturation observed in co-expression of C-terminal trun- cations with the wild-type core protein (Fig. 5) favours the last supposition, since 8-to 80-fold reduction of HBV DNA synthesis reflects the different degree of instability of capsids generated by various C-terminal truncations.
Although the assembly of mosaic nucleocapsids from different types of core proteins has been demonstrated (Chang et al., 1994 ; Ulrich et al., 1998) , it is unclear whether coexpression of mutant with wild-type core protein will reduce or inhibit wild-type viral DNA maturation (Scaglioni et al., 1994 (Scaglioni et al., , 1996 von Weizsacker et al., 1996 ; Wands et al., 1997) . A decrease in HBV DNA maturation may be due to the formation of less stable mosaic capsids as postulated above. Recently, the influence of C-terminal truncation on capsid assembly has been well characterized. It is now known that the segment between aa 129-149 forms an arm-like structure that plays a critical role in capsid assembly (Metzger & Bringas, 1998) . Residue 150 has been localized on the inner side of the capsid around the 5-fold and 6-fold symmetry axes (Zlotnick et al., 1997) . Capsids formed by C-terminally truncated core proteins ending at residue 144 present a hole around the 6-fold symmetry axes that is not present in wild-type capsids (Crowther et al., 1994) . Therefore, any truncation or introduction of a stretch of positively charged amino acids at the C terminus of the core protein could generate instability of mosaic capsids. In this study, we have observed that the effect of mosaic capsids on the retention of pregenome and kinase activity is different. There is an 8-fold reduction in DNA repairing signal in the presence of FlagC151 (Fig. 5 , lane 5 vs lane 2) whereas no significant change in phosphorylated HisC183 was observed in the presence or absence of FlagC151 (Fig. 6 a, lane 4 vs lane 2) .
Trans-complementation between two defective pregenomes of HBV DNA has been largely used to define the elements required for pregenome packaging and genome maturation (Schlicht et al., 1989 ; Chiang et al., 1990 Chiang et al., , 1992 Yu & Summers, 1991 ; von Weizsacker et al., 1995) . In this study, we have employed triple-plasmid transfection and demonstrated that three different less than full-length pregenomic RNAs (3n0, 1n9 and 1n0 kb) could be successfully encapsidated from a single transfection (Fig. 7) . To our knowledge, the 1n0 kb HBV DNA may be derived from the smallest pregenome of HBV being encapsidated and reported so far. Since the 1n0 kb band signal results from the filled-in gap of HBV DNA, it may provide insight into the mechanism of immature termination of the plus strand, which is the hallmark of hepadnaviral DNA (Tiollais et al., 1981) .
The finding of encapsidation of three less than full-length pregenomes raised a question regarding the mechanism of pregenome encapsidation. In the two-plasmid transfection studies, the higher intensity of the repaired 3n0 kb band as compared with that of the 1n9 kb band (2 : 1) is probably due to the fact that 3n0 kb RNA can direct polymerase synthesis and can act as cis-preference packaging (Hirsch et al., 1990) . In contrast, such cis-preference packaging of polymerase-producing RNA apparently did not happen in the triple-plasmid transfection, since the 3n0 kb DNA is the weakest signal among three repaired HBV DNAs (Fig. 7, lane 4) . Although the mutated core proteins and various forms of less than full-length pregenomes used in this study do not occur in vivo, competition for pregenome packaging between core internal deletion and wild-type full-length pregenomes was reported in chronic hepatitis patients (Yuan et al., 1998 a, b) . Furthermore, competition between full-length and spliced pregenomes for encapsidation was also commonly observed, since only a minute amount of defective particles containing spliced RNA was detected in the sera of HBV carriers (Terre! et al., 1991 ; R. L. Kuo & T.-S. Su, personal communication) . Therefore, the triple-plasmid transfection system can be a tool for exploring the limiting factors involved in the competition of differently sized pregenome encapsidation.
At present, how core protein, polymerase and pregenome interact to assemble into replication-competent nucleocapsids is still largely unknown. Jeng et al. (1993) have demonstrated that the core-polymerase interaction occurs in HBV nucleocapsids but the exact contact sites for these two proteins have not yet been determined. Results from this study suggest that the C terminus of wild-type core protein, in addition to interacting with a pregenome, may also be a site for direct interaction with a kinase or cellular factor. Several lines of evidence indicate that the core protein can be phosphorylated in vivo (Roossinck & Siddiqui, 1987) and in vitro (Albin & Robinson, 1980 ; Feitelson et al., 1982 ; Gerlich et al., 1982 ; Duclos-Valle! e et al., 1998) and that kinases can be incorporated into nucleocapsids (Albin & Robinson, 1980 ; Kann & Gerlich, 1994 ; Kau & Ting, 1998) . Additionally, two cellular factors, including the heat shock protein 90 complex (Hu & Seeger, 1996 ; Hu et al., 1997) and terminal-proteinassociated kinase (Kau & Ting, 1997 , have been found to interact with polymerase and are present in virus particles. Therefore, it will be interesting to know whether core mutants generated in this study either lose the ability to bind cellular kinases or factors or\and induce the instability of nucleocapsids.
